Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis

被引:24
作者
Xie, Yuanyuan [1 ]
Liu, Shuo [1 ]
Wang, Liudi [1 ]
Yang, Hui [1 ]
Tai, Chenxu [1 ]
Ling, Li [2 ,3 ]
Chen, Libo [2 ,3 ]
Liu, Shanshan [4 ]
Wang, Bin [1 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Clin Stem Cell Ctr, 321 Zhongshan Rd, Nanjing 210000, Peoples R China
[2] Hua Zhong Univ Sci & Technol, Union Shenzhen Hosp, Univ Hlth Sci Ctr, Dept Endocrinol, Shenzhen 518052, Guangdong, Peoples R China
[3] 6th Affiliated Hosp Shenzhen, Shenzhen 518052, Guangdong, Peoples R China
[4] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Med Sch, Nanjing 210000, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell therapy; Umbilical cord mesenchymal stromal cells; Heterogeneity; Differentiation; Immunomodulation; Liver fibrosis; STEM-CELLS; BONE; DIFFERENTIATION; THERAPY; PROLIFERATION; IMMUNOMODULATION; TRANSPLANTATION; OSTEOGENESIS; MECHANISMS; DISEASES;
D O I
10.1186/s13287-021-02430-6
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background To investigate the heterogeneities of human umbilical cord mesenchymal stromal cells (HUCMSCs) derived from different donors and their therapeutic variations when applied to mouse liver fibrosis model. Methods The characteristics of HUCMSCs derived from multiple donors were comprehensively analyzed including expressions of surface markers, viability, growth curve, karyotype analysis, tumorigenicity, differentiation potentials, and immune regulation capability. Then, the HUCMSCs with distinct immunomodulatory effects were applied to treat mouse liver fibrosis and their therapeutic effects were observed. Results The HUCMSCs derived from multiple donors kept a high consistency in surface marker expressions, viability, growth curve, and tumorigenicity in nude mice but had robust heterogeneities in differentiation potentials and immune regulations. In addition, three HUCMSC lines applied to mice liver fibrosis model had different therapeutic outcomes, in line with individual immune regulation capability. Conclusion The HUCMSCs derived from different donors have individual heterogeneity, which potentially lead to distinct therapeutic outcomes in mouse liver fibrosis, indicating we could make use of the donor-variation of MSCs to screen out guaranteed general indicators of MSCs for specific diseases in further stromal cell therapy.
引用
收藏
页数:17
相关论文
共 50 条
[41]   Human Umbilical Cord-Derived Mesenchymal Stem Cells Downregulate Inflammatory Responses by Shifting the Treg/Th17 Profile in Experimental Colitis [J].
Li, Liren ;
Liu, Suzhe ;
Xu, Yue ;
Zhang, Aixian ;
Jiang, Jinxia ;
Tan, Wei ;
Xing, Jing ;
Feng, Guijuan ;
Liu, Hong ;
Huo, Fangxin ;
Tang, Qiyun ;
Gu, Zhifeng .
PHARMACOLOGY, 2013, 92 (5-6) :257-264
[42]   Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation [J].
Zhang, Ying-Cai ;
Liu, Wei ;
Fu, Bin-Sheng ;
Wang, Guo-Ying ;
Li, Hai-Bo ;
Yi, Hui-Min ;
Jiang, Nan ;
Wang, Genshu ;
Zhang, Jian ;
Yi, Shu-Hong ;
Li, Hua ;
Zhang, Qi ;
Yang, Yang ;
Chen, Gui-Hua .
CYTOTHERAPY, 2017, 19 (02) :194-199
[43]   Repair of Rat Calvarial Bone Defect by Using Exosomes of Umbilical Cord-Derived Mesenchymal Stromal Cells Embedded in Chitosan/Hydroxyapatite Scaffolds [J].
Bahar, Dilek ;
Gonen, Zeynep Burcin ;
Gumusderelioglu, Menemse ;
Onger, Mehmet Emin ;
Tokak, Elvan Konuk ;
Ozturk-Kup, Fatma ;
Ozkan, Buket Banu ;
Gokdemir, Nur Seda ;
Cetin, Mustafa .
INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2022, 37 (05) :943-950
[44]   Procoagulant Activity of Umbilical Cord-Derived Mesenchymal Stromal Cells' Extracellular Vesicles (MSC-EVs) [J].
Wright, Adrienne ;
Snyder, Orman ;
He, Hong ;
Christenson, Lane K. ;
Fleming, Sherry ;
Weiss, Mark L. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
[45]   Transplantation of umbilical cord-derived mesenchymal stem cells promotes the recovery of thin endometrium in rats [J].
Zhang, Lu ;
Li, Ying ;
Dong, Yi-Chao ;
Guan, Chun-Yi ;
Tian, Shi ;
Lv, Xiao-Dan ;
Li, Jian-Hui ;
Su, Xing ;
Xia, Hong-Fei ;
Ma, Xu .
SCIENTIFIC REPORTS, 2022, 12 (01)
[46]   Umbilical cord-derived mesenchymal stromal cells: predictive obstetric factors for cell proliferation and chondrogenic differentiation [J].
Léonore Avercenc-Léger ;
Philippe Guerci ;
Jean-Marc Virion ;
Ghislaine Cauchois ;
Sébastien Hupont ;
Rachid Rahouadj ;
Jacques Magdalou ;
Jean-François Stoltz ;
Danièle Bensoussan ;
Céline Huselstein ;
Loïc Reppel .
Stem Cell Research & Therapy, 8
[47]   Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products [J].
Miryam Mebarki ;
Camille Abadie ;
Jérôme Larghero ;
Audrey Cras .
Stem Cell Research & Therapy, 12
[48]   Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products [J].
Mebarki, Miryam ;
Abadie, Camille ;
Larghero, Jerome ;
Cras, Audrey .
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[49]   Impact of Tissue Factor Gene Knockout on Coagulation Properties of Umbilical Cord-Derived Multipotent Mesenchymal Stromal/Stem Cells [J].
Heidari, Zahra ;
Fallahi, Jafar ;
Sisakht, Mohsen ;
Safari, Fatemeh ;
Hosseini, Kamran ;
Bahmanimehr, Ardeshir ;
Savardashtaki, Amir ;
Khajeh, Sahar ;
Tabei, Seyed Mohammad Bagher ;
Razban, Vahid .
CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (08)
[50]   Optimization of Culture Conditions for the Expansion of Umbilical Cord-Derived Mesenchymal Stem or Stromal Cell-Like Cells Using Xeno-Free Culture Conditions [J].
Hatlapatka, Tim ;
Moretti, Pierre ;
Lavrentieva, Antonina ;
Hass, Ralf ;
Marquardt, Nicole ;
Jacobs, Roland ;
Kasper, Cornelia .
TISSUE ENGINEERING PART C-METHODS, 2011, 17 (04) :485-493